INS and diabetes mellitus: CsA is a diabetogenic agent when its use is prolonged [36] Indeed, posttransplant diabetes mellitus (PTDM) induced by CsA treatment is a frequent and serious complication after solid organ transplantation, and is considered to be a type of secondary diabetes mellitus involving impaired insulin secretion and insulin resistance [2].